Rethinking the national quality framework: Improving the quality and safety of alcohol and other drug treatment in Australia

被引:0
|
作者
Henriksen, Simone M. [1 ,2 ]
机构
[1] Univ Sunshine Coast, Sch Law & Soc, Sippy Downs, Qld, Australia
[2] 110 North Maleny Rd, Maleny, Qld 4552, Australia
关键词
enforcement; licensing; monitoring; national quality framework; quality improvement; HEALTH-CARE; ACCREDITATION; ABUSE; SECTOR; IMPACT; MODEL; RISK; LAW;
D O I
10.1111/rego.12554
中图分类号
D9 [法律]; DF [法律];
学科分类号
0301 ;
摘要
The national quality framework (NQF) has been implemented to improve the safety and quality of alcohol and other drug (AOD) treatment and provide a nationally consistent approach to treatment quality in Australia. At the same time, concerns have been raised that, in the absence of appropriate regulatory structures to support the NQF, the quality and safety of AOD treatment services cannot be guaranteed in Australia. An effective enforcement strategy is critical to the ability of the NQF to provide a nationally consistent approach to the delivery of AOD treatment in Australia. The monitoring and enforcement strategy proposed by the NQF encompasses two different mechanisms. For specialist AOD treatment providers in receipt of government funding, monitoring and enforcement of the NQF will occur via contractual arrangements. For providers not in receipt of government funding, monitoring and enforcement will be managed by regulatory mechanisms as decided by each jurisdiction. This proposed enforcement strategy raises the question of whether contractual arrangements are the most effective mechanism for monitoring and enforcing the NQF in publicly funded specialist AOD treatment providers. This paper considers whether a licensing regime may address the shortcomings that arise from the proposed strategy. It argues that the pluralistic approach to the monitoring and enforcement of the NQF will result in substantive differences in how the NQF is enforced both within individual jurisdictions and on a broader national level. A licensing regime, therefore, would be a more appropriate monitoring and enforcement strategy.
引用
收藏
页码:914 / 933
页数:20
相关论文
共 50 条
  • [21] Improving Seafood Safety and Quality
    Borresen, Torger
    JOURNAL OF AQUATIC FOOD PRODUCT TECHNOLOGY, 2018, 27 (05) : 543 - 543
  • [22] Improving Quality and Safety of Thyroidectomy
    Papazian, Michael
    Roland, J. Thomas, Jr.
    Shao, Qianhui
    Vaezi, Alec
    DeLacure, Mark
    Tran, Theresa
    Persky, Michael J.
    Persky, Mark S.
    Jacobson, Adam
    Givi, Babak
    JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 2021, 233 (05) : S172 - S172
  • [23] Improving Quality and Safety of Thyroidectomy
    Timen, M.
    Moses, Lindsey
    Givi, Babak
    JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 2020, 231 (04) : S191 - S191
  • [24] Improving Wine Quality and Safety
    Marangon, Matteo
    Kallithraka, Stamatina
    BEVERAGES, 2021, 7 (02):
  • [25] Perceptions of purchasing and payment mechanisms in alcohol and other drug treatment services in Australia: A qualitative study involving alcohol and other drug service providers and purchasers of treatment
    van de Ven, Katinka
    Ritter, Alison
    Berends, Lynda
    Chalmers, Jenny
    Lancaster, Kari
    DRUG AND ALCOHOL REVIEW, 2020, 39 (02) : 189 - 197
  • [26] NATIONAL QUALITY AWARD - THE FRAMEWORK IS THERE
    COLLINS, FC
    QUALITY PROGRESS, 1987, 20 (07) : 4 - 4
  • [27] INCENTIVES AND ALERTS FOR IMPROVING ALCOHOL AND OTHER DRUG USE TREATMENT IN WASHINGTON STATE
    Garnick, D. W.
    Horgan, C. M.
    Acevedo, A.
    Lee, M. T.
    Ritter, G.
    Merrick, E.
    Panas, L.
    Huber, A.
    Campbell, K.
    Larson, E.
    Wrede, F.
    ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH, 2014, 38 : 67A - 67A
  • [28] The non-government alcohol and other drug workforce in Australia: Findings from a national survey
    Roche, Ann M.
    Skinner, Natalie
    DRUG AND ALCOHOL REVIEW, 2021, 40 (06) : 1003 - 1012
  • [29] Safety, quality, and the national surgical quality improvement program
    Khuri, Shukri F.
    AMERICAN SURGEON, 2006, 72 (11) : 994 - 998
  • [30] Drug safety, drug quality, drug analysis
    Goeroeg, Sandor
    JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 2008, 48 (02) : 247 - 253